Business
Currency:SGD
2024/FY
Stock NameRevenueRatio
Specialty Pharmaceutical5.65M94.86%
Nutraceutical508K8.52%
Inter-segment sales-202K-3.39%
Region
Currency:SGD
2024/FY
Stock NameRevenueRatio
Australia5.47M91.71%
China408K6.85%
Singapore81K1.36%
United States of America5K0.08%